Form 4: Labcorp EVP Converts RSUs, Sells Shares for Tax

Labcorp's EVP of Diagnostics, Bryan T. Vaughn, converted restricted stock units into common stock and subsequently sold shares to cover tax obligations.

Summary

• Bryan T. Vaughn, EVP, Diagnostics at Labcorp Holdings Inc. (LH), reported transactions involving common stock and restricted stock units (RSUs).
• On February 6, 2026, 180 RSUs vested and were converted into common stock.
• On February 6, 2026, 61 shares of common stock were disposed of at $277.20 per share to satisfy tax withholding obligations.
• On February 7, 2026, 178 RSUs vested and were converted into common stock.
• On February 9, 2026, 61 shares of common stock were disposed of at $274.01 per share to satisfy tax withholding obligations.
• Following these transactions, Vaughn beneficially owns 5,382.5702 shares of common stock directly and 3,624 restricted stock units.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive report. While there are share sales, they are explicitly for tax withholding, a common and expected part of executive compensation. The executive retains a substantial equity stake, indicating continued alignment.

Positives

• Executive Bryan T. Vaughn continues to hold a significant number of common shares (5,382.5702) and restricted stock units (3,624), indicating continued alignment with shareholder interests.
• The vesting of restricted stock units represents a planned compensation event for the executive.

Negatives

• The executive sold a total of 122 shares of common stock across two transactions to cover tax withholding obligations, which is a reduction in direct share ownership.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, particularly those involving the vesting of equity awards and subsequent sales for tax purposes, are common occurrences in publicly traded companies, especially within the healthcare diagnostics sector where executive compensation often includes significant equity components. These routine transactions typically do not signal a change in company fundamentals or executive confidence.

Stakeholder Impact

• Shareholders: The transactions are routine and do not indicate a change in company performance or executive confidence. The executive's continued significant equity holding aligns interests.

Key Dates

Recommendation

The filing details routine insider transactions related to executive compensation (vesting and tax-related sales). These are common and often pre-scheduled events that do not typically reflect a change in the company's fundamental outlook or the executive's long-term confidence. Therefore, a seasoned investor would likely maintain their current position based solely on this filing.

Keywords

Labcorp Holdings Inc., LH, Bryan T. Vaughn, insider trading, Form 4, restricted stock units, RSU, common stock, executive compensation, stock vesting, tax withholding